Skip to menu Skip to content Skip to footer

2018

Journal Article

Work environment risks for health care workers with cystic fibrosis

Bell, Scott C., Armstrong, David, Harrington, Glenys, Jardine, Luke, Divakaran, Rebekah, Loff, Bebe, Middleton, Peter G., McDonald, Tim, Rowland, Karen, Wishart, Michael, Wood, Michelle E. and Stuart, Rhonda L. (2018). Work environment risks for health care workers with cystic fibrosis. Respirology, 23 (12), 1190-1197. doi: 10.1111/resp.13404

Work environment risks for health care workers with cystic fibrosis

2018

Journal Article

Whole genome sequencing reveals the emergence of a Pseudomonas aeruginosa shared strain sub-lineage among patients treated within a single cystic fibrosis centre

Wee, Bryan A., Tai, Anna S., Sherrard, Laura J., Ben Zakour, Nouri L., Hanks, Kirt R., Kidd, Timothy J., Ramsay, Kay A., Lamont, Iain, Whiley, David M., Bell, Scott C. and Beatson, Scott A. (2018). Whole genome sequencing reveals the emergence of a Pseudomonas aeruginosa shared strain sub-lineage among patients treated within a single cystic fibrosis centre. BMC Genomics, 19 (1) 644, 644. doi: 10.1186/s12864-018-5018-x

Whole genome sequencing reveals the emergence of a Pseudomonas aeruginosa shared strain sub-lineage among patients treated within a single cystic fibrosis centre

2018

Journal Article

Face Masks Reduce the Release of Pseudomonas aeruginosa Cough Aerosols when Worn for Clinically-Relevant Time Periods

Stockwell, Rebecca E., Wood, Michelle E., He, Congrong, Sherrard, Laura J., Ballard, Emma L., Kidd, Timothy J., Johnson, Graham R., Knibbs, Luke D., Morawska, Lidia, Bell, Scott C., CF Cough Aerosol Group and Duplancic, Christine (2018). Face Masks Reduce the Release of Pseudomonas aeruginosa Cough Aerosols when Worn for Clinically-Relevant Time Periods. American Journal of Respiratory and Critical Care Medicine, 198 (10) rccm.201805-0823LE, 1339-1342. doi: 10.1164/rccm.201805-0823LE

Face Masks Reduce the Release of Pseudomonas aeruginosa Cough Aerosols when Worn for Clinically-Relevant Time Periods

2018

Journal Article

Transcriptomic analysis of longitudinal Burkholderia pseudomallei infecting the cystic fibrosis lung

Price, Erin P., Viberg, Linda T., Kidd, Timothy J., Bell, Scott C., Currie, Bart J. and Sarovich, Derek S. (2018). Transcriptomic analysis of longitudinal Burkholderia pseudomallei infecting the cystic fibrosis lung. Microbial Genomics, 4 (8) 000194. doi: 10.1099/mgen.0.000194

Transcriptomic analysis of longitudinal Burkholderia pseudomallei infecting the cystic fibrosis lung

2018

Journal Article

Anomalies in T cell function are associated with individuals at risk of Mycobacterium abscessus complex infection

Lutzky, Viviana P., Ratnatunga, Champa N., Smith, Daniel J., Kupz, Andreas, Doolan, Denise L., Reid, David W., Thomson, Rachel M., Bell, Scott C. and Miles, John J. (2018). Anomalies in T cell function are associated with individuals at risk of Mycobacterium abscessus complex infection. Frontiers in Immunology, 9 (June) 1319, 1319. doi: 10.3389/fimmu.2018.01319

Anomalies in T cell function are associated with individuals at risk of Mycobacterium abscessus complex infection

2018

Journal Article

Optimism, opportunities, outcomes: the Australian Cystic Fibrosis Data Registry

Ahern, Susannah, Sims, Geoff, Earnest, Arul and Bell, Scott C. (2018). Optimism, opportunities, outcomes: the Australian Cystic Fibrosis Data Registry. Internal Medicine Journal, 48 (6), 721-723. doi: 10.1111/imj.13807

Optimism, opportunities, outcomes: the Australian Cystic Fibrosis Data Registry

2018

Journal Article

Biomarkers: their role in CFTR modulator therapies from early development to the clinic

Bell, Scott C. and Wood, Michelle E. (2018). Biomarkers: their role in CFTR modulator therapies from early development to the clinic. American Journal of Respiratory and Critical Care Medicine, 197 (11), 1375-1376. doi: 10.1164/rccm.201801-0177ED

Biomarkers: their role in CFTR modulator therapies from early development to the clinic

2018

Journal Article

Inhaled corticosteroids for bronchiectasis (review)

Kapur, Nitin, Petsky, Helen L., Bell, Scott, Kolbe, John and Chang, Anne B. (2018). Inhaled corticosteroids for bronchiectasis (review). Cochrane Database of Systematic Reviews, 2018 (5) CD000996. doi: 10.1002/14651858.CD000996.pub3

Inhaled corticosteroids for bronchiectasis (review)

2018

Journal Article

Bronchiectasis: yet another systemic disease?

Geake, James and Bell, Scott C. (2018). Bronchiectasis: yet another systemic disease?. Respirology, 23 (9), 797-798. doi: 10.1111/resp.13322

Bronchiectasis: yet another systemic disease?

2018

Journal Article

Cystic fibrosis pathogens survive for extended periods within cough-generated droplet nuclei

Wood, Michelle E., Stockwell, Rebecca E., Johnson, Graham R., Ramsay, Kay A., Sherrard, Laura J., Kidd, Timothy J., Cheney, Joyce, Ballard, Emma L., O'Rourke, Peter, Jabbour, Nassib, Wainwright, Claire E., Knibbs, Luke D., Sly, Peter D., Morawska, Lidia and Bell, Scott C. (2018). Cystic fibrosis pathogens survive for extended periods within cough-generated droplet nuclei. Thorax, 74 (1), thoraxjnl-2018. doi: 10.1136/thoraxjnl-2018-211567

Cystic fibrosis pathogens survive for extended periods within cough-generated droplet nuclei

2018

Journal Article

The experience of men and women with cystic fibrosis who have become a parent: a qualitative study

Jessup, Melanie, Li, Anne, Fulbrook, Paul and Bell, Scott (2018). The experience of men and women with cystic fibrosis who have become a parent: a qualitative study. Journal of Clinical Nursing, 27 (7-8), 1702-1712. doi: 10.1111/jocn.14229

The experience of men and women with cystic fibrosis who have become a parent: a qualitative study

2018

Journal Article

ECFS best practice guidelines: the 2018 revision

Castellani, Carlo, Duff, Alistair J. A., Bell, Scott C., Heijerman, Harry G. M., Munck, Anne, Ratjen, Felix, Sermet-Gaudelus, Isabelle, Southern, Kevin W., Barben, Jurg, Flume, Patrick A., Hodková, Pavla, Kashirskaya, Nataliya, Kirszenbaum, Maya N., Madge, Sue, Oxley, Helen, Plant, Barry, Schwarzenberg, Sarah Jane, Smyth, Alan R., Taccetti, Giovanni, Wagner, Thomas O. F., Wolfe, Susan P. and Drevinek, Pavel (2018). ECFS best practice guidelines: the 2018 revision. Journal of Cystic Fibrosis, 17 (2), 153-178. doi: 10.1016/j.jcf.2018.02.006

ECFS best practice guidelines: the 2018 revision

2018

Journal Article

Face masks and cough etiquette reduce the cough aerosol concentration of Pseudomonas aeruginosa in people with cystic fibrosis

Wood, Michelle E., Stockwell, Rebecca E., Johnson, Graham R., Ramsay, Kay A., Sherrard, Laura J., Jabbour, Nassib, Ballard, Emma, O'Rourke, Peter, Kidd, Timothy J., Wainwright, Claire E., Knibbs, Luke D., Sly, Peter D., Morawska, Lidia and Bell, Scott C. (2018). Face masks and cough etiquette reduce the cough aerosol concentration of Pseudomonas aeruginosa in people with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine, 197 (3), 338-355. doi: 10.1164/rccm.201707-1457OC

Face masks and cough etiquette reduce the cough aerosol concentration of Pseudomonas aeruginosa in people with cystic fibrosis

2018

Journal Article

Differential expression of genes and receptors in monocytes from patients with cystic fibrosis

Tarique, Abdullah A., Sly, Peter D., Cardenas, Diana G., Luo, Lin, Stow, Jennifer L., Bell, Scott C., Wainwright, Claire E. and Fantino, Emmanuelle (2018). Differential expression of genes and receptors in monocytes from patients with cystic fibrosis. Journal of Cystic Fibrosis, 18 (3), 342-348. doi: 10.1016/j.jcf.2018.07.012

Differential expression of genes and receptors in monocytes from patients with cystic fibrosis

2018

Journal Article

How many days are enough?: capturing routine human mobility

Stanley, Kevin, Yoo, Eun-Hye, Paul, Tuhin and Bell, Scott (2018). How many days are enough?: capturing routine human mobility. International Journal of Geographical Information Science, 32 (7), 1485-1504. doi: 10.1080/13658816.2018.1434888

How many days are enough?: capturing routine human mobility

2018

Journal Article

Lower airway microbiota for biomarker measurements of cystic fibrosis disease progression?

Sherrard, Laura J. and Bell, Scott C. (2018). Lower airway microbiota for biomarker measurements of cystic fibrosis disease progression?. Thorax, 73 (11), 1001-1003. doi: 10.1136/thoraxjnl-2018-212165

Lower airway microbiota for biomarker measurements of cystic fibrosis disease progression?

2017

Journal Article

Antibiotic perturbation of mixed-strain Pseudomonas aeruginosa infection in patients with cystic fibrosis

Tai, Anna S., Sherrard, Laura J., Kidd, Timothy J., Ramsay, Kay A., Buckley, Cameron, Syrmis, Melanie, Grimwood, Keith, Bell, Scott C. and Whiley, David M. (2017). Antibiotic perturbation of mixed-strain Pseudomonas aeruginosa infection in patients with cystic fibrosis. BMC pulmonary medicine, 17 (1) 138, 1-10. doi: 10.1186/s12890-017-0482-7

Antibiotic perturbation of mixed-strain Pseudomonas aeruginosa infection in patients with cystic fibrosis

2017

Journal Article

Early intervention of cystic fibrosis pulmonary exacerbations based on home monitoring eICE through the looking glass

Bell, Scott C. (2017). Early intervention of cystic fibrosis pulmonary exacerbations based on home monitoring eICE through the looking glass. American Journal of Respiratory and Critical Care Medicine, 196 (9), 1090-1092. doi: 10.1164/rccm.201706-1207ED

Early intervention of cystic fibrosis pulmonary exacerbations based on home monitoring eICE through the looking glass

2017

Journal Article

Learning's from the Editors Desk – 2017

Bell, Scott C., Castellani, Carlo and Flume, Patrick A. (2017). Learning's from the Editors Desk – 2017. Journal of Cystic Fibrosis, 16 (6), 645-646. doi: 10.1016/j.jcf.2017.10.001

Learning's from the Editors Desk – 2017

2017

Journal Article

The treatment of the pulmonary and extrapulmonary manifestations of cystic fibrosis

Chin, Melanie, Aaron, Shawn D. and Bell, Scott C. (2017). The treatment of the pulmonary and extrapulmonary manifestations of cystic fibrosis. Presse Medicale, 46 (6), E139-E164. doi: 10.1016/j.lpm.2016.11.030

The treatment of the pulmonary and extrapulmonary manifestations of cystic fibrosis